Altimmune, Inc. logo ALT - Altimmune, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 12
HOLD 3
SELL 0
STRONG
SELL
0
| PRICE TARGET: $11.25 DETAILS
HIGH: $20.00
LOW: $2.50
MEDIAN: $11.25
CONSENSUS: $11.25
UPSIDE: 287.93%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Revenue
Revenue 0.0 0.0 0.4 (0.1) 4.4 8.2 5.8 10.3 0.0 5.2 10.6 10.2 17.9 25.2 24.3 21.0 27.5 32.9 14.6 1.8 0.6
Cost of Revenue 0 0 0 0 0 33.5 0 18.5 18.4 7.2 5.1 4.3 0 0 0 0 0 0 0 0 0.1
Gross Profit 0.0 0.0 0.4 (0.1) 4.4 (25.3) 5.8 (8.1) (18.4) (2.0) 5.6 5.9 17.9 25.2 24.3 21.0 27.5 32.9 14.6 1.8 0.5
Operating Expenses
R&D Expenses 66.4 82.2 65.8 70.5 74.5 49.8 17.8 18.5 18.4 4.8 5.1 9.3 15.3 19.5 21.2 20.9 30.2 31.8 16.6 0 0
SG&A Expenses 28.1 21.0 18.1 17.1 15.4 13.2 8.5 9.8 8.5 11.5 6.2 10.9 13.3 11.6 14.3 18.0 22.4 19.4 13.9 0.5 0.1
Other Expenses 0 0 12.4 0 11.4 (33.5) 1 0.3 0.0 0.0 0.0 (0.0) (0.0) 0.0 0.5 5.7 0.9 0.8 0.7 0.2 0
Operating Expenses 94.5 103.2 96.4 87.7 101.3 29.5 27.3 28.2 16.2 16.5 11.5 20.4 28.8 31.4 36.0 44.5 53.5 52.0 31.1 0.6 0.1
Operating Income
Operating Income (94.5) (103.2) (95.9) (87.7) (96.9) (54.8) (21.5) (42.8) (52.0) (11.3) (3.4) (10.2) (10.8) (6.3) (11.7) (23.6) (26.0) (35.2) (16.5) 1.2 0.3
Interest Expense 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.2 0.4 0.3 0.1 5.9 2.8 2.6 2.1 0 0
Interest Income 7.5 8.1 7.4 2.9 0.2 0.3 0.8 0.2 0.0 0.0 0 0 0.0 0.0 0.0 0.0 0.3 1.2 1.1 1.8 0.6
Profitability
EBITDA (87.0) (94.8) (87.9) (84.4) (96.5) (38.1) (20.2) (44.7) (51.8) (10.9) (3.2) (9.5) (11.1) (4.1) (3.3) (23.3) (28.6) (33.0) (15.8) (14.0) 0.3
EBIT (87.1) (95.0) (88.4) (84.9) (97.1) (38.5) (20.6) (45.0) (51.9) (11.0) (0.9) (9.7) (11.3) (4.4) (3.7) (28.9) (26.0) (19.1) (16.5) (14.5) 0.3
Income Before Tax (88.8) (95.1) (88.4) (84.9) (97.1) (43.6) (20.6) (45.3) (52.1) 205.0 (3.4) (9.9) (11.7) (4.7) (3,797,573) (34,849,277) (32,279.8) (36,415.1) (13.6) 1.2 0.3
Income Tax Expense (0.7) 0 0 (0.2) 0 5.4 (0.1) (6.1) (5.6) 11.2 0.1 0.1 0.1 0.2 (7.9) 15.9 6.3 17.3 0 0.2 0.0
Net Income (88.1) (95.1) (88.4) (84.7) (97.1) (49.0) (20.5) (39.2) (46.4) 193.9 (3.4) (10.0) (11.7) (4.9) (3.8) (34.8) (32.3) (36.4) (13.6) 1.0 0.3
Per Share Data
EPS (Basic) -1.00 -1.34 -1.66 -1.81 -2.35 -1.91 -1.56 -13.98 -108.77 -49.80 -16.13 -51.91 -69.40 -30.55 -24.07 -323.59 -351.19 -476.15 -431.69 23.63 12.00
EPS (Diluted) -1.00 -1.34 -1.66 -1.81 -2.35 -1.91 -1.56 -13.98 -108.77 -49.80 -16.13 -51.91 -69.40 -30.55 -24.07 -323.59 -351.19 -476.15 -431.69 21.71 9.00
Shares Outstanding 88.1 71.0 53.2 46.9 41.3 25.6 13.1 2.8 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008
Current Assets
Cash & Cash Equivalents 43.8 36.9 135.1 111.1 190.3 115.9 9.0 33.7 8.8 154.0 2.7 19.8
Short-Term Investments 229.7 95.0 62.7 73.8 0 100.0 28.3 0 0 66.8 3.1 3.2
Net Receivables 1.7 3.1 4.9 2.5 5.8 12.4 1.7 4.5 10.2 1.0 18.7 10.3
Inventory 0 0 0 0 0 0 0 0 3.5 0 0 0
Other Current Assets 3.0 2.2 7.0 5.4 0.0 0.0 0.0 0.6 3.5 0.8 0 12
Total Current Assets 278.2 137.3 209.6 192.8 204.1 230.3 39.4 39.4 23.5 222.3 24.2 46.1
Non-Current Assets
Property, Plant & Equipment 0.3 0.4 0.7 1.1 1.4 2.0 1.8 1.3 0.6 0.1 6.3 5.3
Goodwill 0 0 0 0 0 0 0 0 0 18.8 2.3 2.5
Intangible Assets 0 0 0 12.4 12.4 12.8 12.7 13.9 38.7 15.0 0.9 0.9
Long-Term Investments 0 0 0 0 0 0 0 (58.5) (5,938.4) 0 0 0
Other Non-Current Assets 1.4 1.6 0.4 0.6 0.9 0.1 0.1 0.2 0.2 0 0.3 1.5
Total Non-Current Assets 1.7 2.1 1.0 14.1 14.7 14.9 14.7 15.4 39.6 2.5 9.8 10.2
Total Assets 279.9 139.3 210.6 206.9 218.9 245.1 54.1 54.8 63.0 224.7 34.1 56.4
Current Liabilities
Account Payables 2.7 0.2 2.1 4.8 2.0 0.6 0.0 0.4 0.1 2.0 1.9 3.9
Short-Term Debt 0 0 0 0 0 0 0 0.1 0.0 0.5 0 17.4
Deferred Revenue 0 0 0 0 0 0.0 0.1 0.0 0.0 0.0 0 0
Other Current Liabilities 0 0 0 0 6.1 8.7 0 2.8 1.9 0.6 10.2 13.7
Total Current Liabilities 15.0 10.5 12.1 17.1 18.3 12.0 3.9 4.5 3.8 204.8 13.5 35.9
Non-Current Liabilities
Long-Term Debt 34.3 0 0 0 0 0 0 0.5 0.6 0.5 17.4 0.9
Deferred Tax Liabilities 0 0 0 0 0 (0.2) 0 0.1 5.9 (0.7) 0 0
Other Non-Current Liabilities 4.4 3.9 4.2 3.9 0.3 5.8 2.9 1.4 3.8 0.0 1.3 0.6
Total Non-Current Liabilities 40.0 5.3 4.4 4.6 1.5 7.2 4.6 1.9 10.5 0.4 18.7 1.6
Total Liabilities 55.0 15.8 16.5 21.6 19.7 19.2 8.5 6.4 14.4 205.3 32.2 37.4
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (649.5) (561.4) (466.3) (377.9) (293.2) (186.4) (137.4) (116.9) (77.7) (29.9) (156.3) (123.8)
Accumulated Other Comprehensive Income (4.9) (5.0) (5.0) (5.2) (5.0) (5.0) (5.0) (5.0) (4.6) (0.0) 1.2 0.4
Total Stockholders' Equity 224.9 123.5 194.1 185.3 199.1 225.9 45.5 48.3 48.7 19.5 1.9 19.0
Total Liabilities & Equity 279.9 139.3 210.6 206.9 218.9 245.1 54.1 54.8 63.0 224.7 34.1 56.4
Debt Metrics
Total Debt 35.7 1.7 0.7 1.1 1.5 1.8 1.7 0.6 0.0 1.0 17.4 18.3
Net Debt (8.1) (35.2) (134.4) (110.0) (188.8) (114.1) (7.2) (33.1) (8.7) (153.0) 14.8 (1.4)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2005
Operating Activities
Net Income (88.1) (95.1) (88.4) (84.7) (97.1) (49.0) (20.5) (39.2) (46.4) 193.9 0.3
Depreciation & Amortization 0.1 0.2 0.5 0.5 0.6 0.4 0.4 0.3 0.1 0.1 0
Stock-Based Compensation 16.1 14.4 10.6 8.1 5.5 2.6 0 0.8 1.4 2.2 0
Change in Working Capital 6.8 4.5 (8.3) 14.1 (0.3) (4.5) 1.8 7.0 (11.3) 4.2 0.3
Other Non-Cash Items (1.7) (3.9) 9.8 (0.6) 13.0 16.2 8.8 27.9 2,653.0 1.0 0
Operating Cash Flow (67.5) (79.8) (75.8) (62.6) (78.2) (34.3) (9.6) (9.4) (20.2) 201.5 0.6
Investing Activities
Capital Expenditure (0.0) 0 (0.0) (0.1) (12.3) (0.3) (0.0) (1.0) (0.2) (0.0) 0
Acquisitions 0 0 0 0 0 0 0 0.0 13.7 0 0
Purchases of Investments (285.4) (115.7) (88.6) (73.3) (7.6) (128.3) (28.3) 0 0 (66.8) 0
Sales/Maturities of Investments 153.0 87.3 102.4 0 107.4 56.4 0 0 0.2 0 0
Other Investing Activities 0 0 0 0 (0.2) (0.1) 0 0.0 0.2 0.0 (68.6)
Investing Cash Flow (132.5) (28.4) 13.7 (73.4) 87.5 (72.2) (28.3) (1.0) 13.7 (66.9) (68.6)
Financing Activities
Net Debt Issuance 33.9 0 0 0 0 0 (0.3) (1.5) 2.8 (0.1) 0
Stock Repurchased 0 0 0 0 0 0 0 (2.4) 0 0 (5.7)
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (0.7) 0.1 (0.5) 0.4 0.1 41.2 0.1 (1.0) 0.0 (0.6) 0
Financing Cash Flow 206.8 10.0 86.1 56.8 65.1 213.5 12.5 32.5 15.8 3.8 69.5
Cash Position
Net Change in Cash 6.8 (98.2) 24.0 (79.2) 74.4 107.0 (25.4) 22.0 9.4 138.4 1.4
Cash at Beginning 37.0 135.2 111.1 190.3 116.0 9.0 34.4 12.3 2.9 15.6 0
Cash at End 43.8 37.0 135.2 111.1 190.3 116.0 9.0 34.4 12.3 154.0 1.4
Free Cash Flow (67.5) (79.8) (75.9) (62.7) (90.5) (34.6) (9.6) (10.4) (20.4) 201.5 0.6
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Income Statement
Revenue 0.0 0.0 0.4 (0.1) 4.4 8.2 5.8 10.3 0.0 5.2 10.6 10.2 17.9 25.2 24.3 21.0 27.5 32.9 14.6 1.8 0.6
Gross Profit 0.0 0.0 0.4 (0.1) 4.4 (25.3) 5.8 (8.1) (18.4) (2.0) 5.6 5.9 17.9 25.2 24.3 21.0 27.5 32.9 14.6 1.8 0.5
Operating Income (94.5) (103.2) (95.9) (87.7) (96.9) (54.8) (21.5) (42.8) (52.0) (11.3) (3.4) (10.2) (10.8) (6.3) (11.7) (23.6) (26.0) (35.2) (16.5) 1.2 0.3
Net Income (88.1) (95.1) (88.4) (84.7) (97.1) (49.0) (20.5) (39.2) (46.4) 193.9 (3.4) (10.0) (11.7) (4.9) (3.8) (34.8) (32.3) (36.4) (13.6) 1.0 0.3
EPS (Diluted) -1.00 -1.34 -1.66 -1.81 -2.35 -1.91 -1.56 -13.98 -108.77 -49.80 -16.13 -51.91 -69.40 -30.55 -24.07 -323.59 -351.19 -476.15 -431.69 21.71 9.00
Balance Sheet
Cash & Equivalents 43.8 36.9 135.1 111.1 190.3 115.9 9.0 33.7 8.8 154.0 2.7 19.8
Total Assets 279.9 139.3 210.6 206.9 218.9 245.1 54.1 54.8 63.0 224.7 34.1 56.4
Total Debt 35.7 1.7 0.7 1.1 1.5 1.8 1.7 0.6 0.0 1.0 17.4 18.3
Stockholders' Equity 224.9 123.5 194.1 185.3 199.1 225.9 45.5 48.3 48.7 19.5 1.9 19.0
Cash Flow
Operating Cash Flow (67.5) (79.8) (75.8) (62.6) (78.2) (34.3) (9.6) (9.4) (20.2) 201.5 0.6
Capital Expenditure (0.0) 0 (0.0) (0.1) (12.3) (0.3) (0.0) (1.0) (0.2) (0.0) 0
Free Cash Flow (67.5) (79.8) (75.9) (62.7) (90.5) (34.6) (9.6) (10.4) (20.4) 201.5 0.6